F
July 18, 2024 - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
June 3, 2024 - Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer |
Upcoming EventsAug. 1, 2024 - Puma Biotechnology 2Q-2024 Financial Results Conference Call More Past EventsMay 31 - June 4, 2024 - ASCO 2024 Annual MeetingMore May 2, 2024 - Puma Biotechnology 1Q-2024 Financial Results Conference Call More Mar. 6, 2024 - TD Cowen’s 44th Annual Health Care Conference More Feb. 29, 2024 - Puma Biotechnology 4Q-2023 Financial Results Conference Call More Jan. 11, 2024 - B. Riley Securities 4th Annual Oncology Conference More |
Annual Report Archives Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles, CA 90024 424-248-6500 Main 424-248-6501 Fax Medical Inquiries: 1-844-MED-PUMA (1-844-633-7862), or medinfo@pumabiotechnology.com Business Development: info@pumabiotechnology.com Investor Relations: ir@pumabiotechnology.com Follow Us: |
© 2024 Puma Biotechnology, Inc. | Privacy Policy | WA Privacy Policy | Terms of Service | Data Rights Request | Legal Notice | Site Map |